VTR Ventas
SHOP growth keeps compounding, but at 25x FFO the price already discounts the demographic boom.
The story
Ventas owns a senior housing, medical office and life science portfolio, and its senior housing operating portfolio (SHOP) is the growth engine. Occupancy gains and pricing power are flowing through as the 80+ population surges while new supply sits near cycle lows; revenue grew about 16% to 6.78B. The balance sheet is investment grade, and recent growth has been funded mainly with equity issued at a premium multiple. The stock is rate sensitive: at about 25x FFO (1.89B FFO against a 47.17B market cap), it trades like a growth asset whose multiple compresses if long yields rise.
I nudged year-1 growth from 11% to 12% because revenue accelerated about 16% and operating margin expanded again to 14.7%, confirming SHOP operating leverage. Capex of 0.77B is about 41% of FFO, but part of it is development and repositioning rather than maintenance, so I keep a 0.75 AFFO/FFO ratio to reflect SHOP's heavy recurring capex. Terminal growth stays at 3%, below the 4.89% risk-free rate, and beta stays at 0.85; the business is lower risk than the 0.9 industry anchor because of its demographic tailwind and strong balance sheet, but that is offset by operator and labor-cost exposure.
Value drivers
| AFFO growth (Y1) | 12.0% |
| Terminal AFFO growth | 3.0% |
| AFFO / FFO ratio | 75.0% |
| Beta | 0.85 |
| Failure probability | 0.4% |
| Cost of equity | 8.7% |
Valuation bridge
| PV of AFFO (explicit) | 14.35B |
| PV of terminal value | 22.67B |
| Equity value | 36.87B |
| ÷ shares → per share | $69.72 |
Projected AFFO
| Yr | FFO | AFFO | Growth | PV |
|---|---|---|---|---|
| 1 | 2.11B | 1.58B | 12.0% | 1.46B |
| 2 | 2.34B | 1.76B | 11.0% | 1.49B |
| 3 | 2.58B | 1.93B | 10.0% | 1.50B |
| 4 | 2.81B | 2.11B | 9.0% | 1.51B |
| 5 | 3.04B | 2.28B | 8.0% | 1.50B |
| 6 | 3.25B | 2.44B | 7.0% | 1.48B |
| 7 | 3.44B | 2.58B | 6.0% | 1.44B |
| 8 | 3.61B | 2.71B | 5.0% | 1.39B |
| 9 | 3.76B | 2.82B | 4.0% | 1.33B |
| 10 | 3.87B | 2.90B | 3.0% | 1.26B |
Key risks
- Rising long-term rates compress the roughly 25x P/FFO multiple and raise the cost of equity issuance used to fund acquisitions
- Senior housing construction restarts by 2028-2029 as current high returns attract new supply, capping occupancy and rent growth
- Operator labor-cost inflation and tenant credit stress in the medical office and life science segments erode SHOP margins
Catalysts
- SHOP occupancy moving into the high 80s with mid-single-digit rate increases, driving same-store NOI growth in the teens
- Accretive SHOP acquisitions funded with premium-priced equity, plus Fed rate cuts that lower the discount rate